European Radiology

, Volume 24, Issue 3, pp 574–580 | Cite as

Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes

  • Ahmed M. TawfikEmail author
  • A. A. Razek
  • J. Matthias Kerl
  • N. E. Nour-Eldin
  • Ralf Bauer
  • Thomas J. Vogl
Head and Neck



To evaluate whether dual-energy computed tomography (DECT)-derived iodine content and iodine overlay could differentiate between normal, inflammatory and metastatic squamous cell carcinoma (SCC) cervical lymph nodes.


This study was approved by the institutional review board. Sixteen patients with normal lymph nodes, 20 patients with enlarged nodes draining deep cervical inflammations and 23 patients with pathologically proved metastatic SCC nodes who underwent contrast enhanced DECT were retrospectively identified. Iodine content and overlay of 36 normal, 43 inflammatory and 52 metastatic lymph nodes were calculated using circular regions of interest and compared among the three groups. A receiver operating characteristic (ROC) curve was used to determine the sensitivity and specificity of iodine content and overlay for diagnosis of metastatic nodes.


Iodine content (mg/ml) was significantly lower for metastatic lymph nodes (2.34 ± 0.45) than for normal (2.86 ± 0.37) and inflammatory (3.53 ± 0.56) lymph nodes, P < 0.0001. Iodine overlay (HU) was also significantly lower for metastatic lymph nodes (47 ± 11.6) than normal (57.4 ± 8.2) and inflammatory nodes (69.3 ± 11.5), P < 0.0001. The areas under the ROC curve for iodine content and iodine overlay were 0.923 and 0.896.


DECT-derived iodine content and overlay differ significantly among normal, inflammatory and metastatic SCC cervical lymph nodes.

Key points

Derived iodine content can be calculated from contrast-enhanced dual-energy CT.

Derived iodine content and iodine overlay could help characterise cervical lymph nodes.

Iodine parameters were significantly lower in metastatic lymph nodes than normal/inflammatory lymph nodes.

Iodine content appears more sensitive than iodine overlay for lymph node characterisation.


Dual-energy CT Iodine content Iodine overlay Cervical lymph node Lymph node characterisation 



An oral presentation containing some data from this article was presented by the same authors in ECR 2012, with the title “Dual energy CT-derived iodine content and iodine overlay for characterisation of enlarged cervical lymph nodes”.


  1. 1.
    Mack M, Rieger J, Baghi M, Bisdas S, Vogl T (2008) Cervical lymph nodes. Eur J Radiol 66:493–500PubMedCrossRefGoogle Scholar
  2. 2.
    Chong V (2004) Cervical lymphadenopathy: what radiologists need to know. Cancer Imaging 4:116–120PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Nakamura T, Sumi M (2007) Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol 17:1235–1241PubMedCrossRefGoogle Scholar
  4. 4.
    Zenk J, Bozzato A, Steinhart H, Greess H, Iro H (2005) Metastatic and inflammatory cervical lymph nodes as analyzed by contrast-enhanced color-coded Doppler ultrasonography: quantitative dynamic perfusion patterns and histopathologic correlation. Ann Otol Rhinol Laryngol 114:43–47PubMedGoogle Scholar
  5. 5.
    Bisdas S, Baghi M, Huebner F et al (2007) In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck. Eur Radiol 17:251–257PubMedCrossRefGoogle Scholar
  6. 6.
    Bisdas S, Baghi M, Smolarz A et al (2007) Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using 1st-pass contrast-enhanced computed tomography studies. Investig Radiol 42:172–179CrossRefGoogle Scholar
  7. 7.
    Vandecaveye V, De Keyzer F, Vander Poorten V et al (2009) Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 251:134–146PubMedCrossRefGoogle Scholar
  8. 8.
    Abdel Razek A, Gaballa G (2011) Role of perfusion MR imaging in cervical lymphadenopathy. J Comput Assist Tomogr 35:21–25PubMedCrossRefGoogle Scholar
  9. 9.
    Nakagawa T, Yamada M, Suzuki Y (2008) 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 49:1053–1059PubMedCrossRefGoogle Scholar
  10. 10.
    Ng SH, Yen TC, Liao CT et al (2005) 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46:1136–1143PubMedGoogle Scholar
  11. 11.
    Miles KA (1999) Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol 30:198–205PubMedCrossRefGoogle Scholar
  12. 12.
    Swensen SJ, Brown LR, Colby TV, Weaver AL (1995) Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 194:393–398PubMedGoogle Scholar
  13. 13.
    Chae EJ, Song JW, Krauss B et al (2010) Dual-energy computed tomography characterization of solitary pulmonary nodules. J Thorac Imaging 25:301–310PubMedCrossRefGoogle Scholar
  14. 14.
    Chandarana H, Megibow AJ, Cohen BA et al (2011) Iodine quantification with dual-energy CT: phantom study and preliminary experience with renal masses. AJR Am J Roentgenol 196:693–700CrossRefGoogle Scholar
  15. 15.
    Godoy MC, Naidich DP, Marchiori E et al (2009) Basic principles and postprocessing techniques of dual-energy CT: illustrated by selected congenital abnormalities of the thorax. Thorac Imaging 24:152–159CrossRefGoogle Scholar
  16. 16.
    Vogl TJ, Schulz B, Bauer RW, Stöver T, Sader R, Tawfik AM (2012) Dual-energy CT applications in head and neck imaging. AJR Am J Roentgenol 199:34–39CrossRefGoogle Scholar
  17. 17.
    Neville AM, Gupta RT, Miller CM, Merkle EM, Paulson EK, Boll DT (2011) Detection of renal lesion enhancement with dual-energy multidetector CT. Radiology 259:173–183PubMedCrossRefGoogle Scholar
  18. 18.
    Toepker M, Moritz T, Krauss B et al (2012) Virtual non-contrast in second-generation, dual-energy computed tomography: reliability of attenuation values. Eur J Radiol 81:398–405CrossRefGoogle Scholar
  19. 19.
    Kaufmann S, Sauter A, Spira D et al (2013) Tin-filter enhanced dual-energy-CT: image quality and accuracy of CT numbers in virtual noncontrast imaging. Acad Radiol 20:596–603PubMedCrossRefGoogle Scholar
  20. 20.
    Chae EJ, Song JW, Seo JB, Krauss B, Jang YM, Song KS (2008) Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience. Radiology 249:671–681PubMedCrossRefGoogle Scholar
  21. 21.
    Song KD, Kim CK, Park BK, Kim B (2011) Utility of iodine overlay technique and virtual unenhanced images for the characterization of renal masses by dual-energy CT. AJR Am J Roentgenol 197:1076–1082Google Scholar
  22. 22.
    Ascenti G, Mileto A, Krauss B et al (2013) Distinguishing enhancing from nonenhancing renal masses with dual-source dual energy CT: iodine quantification versus standard enhancement measurements. Eur Radiol 23:2288–2295PubMedCrossRefGoogle Scholar
  23. 23.
    Fischbein NJ, Noworolski SM, Henry RG, Kaplan M, Dillon W, Nelson S (2003) Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 24:301–311PubMedGoogle Scholar
  24. 24.
    Naresh KN, Nerurkar AY, Borges AM (2001) Angiogenesis is redundant for tumour growth in lymph node metastases. Histopathology 38:466–470PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2013

Authors and Affiliations

  • Ahmed M. Tawfik
    • 1
    • 2
    Email author
  • A. A. Razek
    • 2
  • J. Matthias Kerl
    • 1
  • N. E. Nour-Eldin
    • 1
  • Ralf Bauer
    • 1
  • Thomas J. Vogl
    • 1
  1. 1.Department of Diagnostic and Interventional RadiologyJohan Wolfgang Goethe University HospitalFrankfurt am MainGermany
  2. 2.Department of Diagnostic and Interventional RadiologyMansoura University HospitalMansouraEgypt

Personalised recommendations